Immunotherapy and Immunotherapy Combinations in Metastatic Castration-Resistant Prostate Cancer

Although most prostate cancers are localized, and the majority are curable, recurrences occur in approximately 35% of men. Among patients with prostate-specific antigen (PSA) recurrence and PSA doubling time (PSADT) less than 15 months after radical prostatectomy, prostate cancer accounted for appro...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2021-01, Vol.13 (2), p.334
Hauptverfasser:	Bansal, Dhruv, Reimers, Melissa A, Knoche, Eric M, Pachynski, Russell K
Format:	Artikel
Sprache:	eng
Schlagworte:	Androgens Antigens Cancer surgery Cancer therapies Cancer vaccines Castration Cell-mediated immunity Chemotherapy Chimeric antigen receptors Clinical trials Deoxyribonucleic acid DNA FDA approval Granulocytes Immune checkpoint Immunomodulation Immunotherapy Lymphocytes Lymphocytes T Melanoma Metastases Metastasis Mortality Patients Peptides Poly(ADP-ribose) polymerase Prostate cancer Prostate-specific antigen Prostatectomy Protein-tyrosine kinase Radiation therapy Review Ribose Tumor microenvironment Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!